Trial Outcomes & Findings for PREMIER: PREvention of Metabolic Illness Through prEcision nutRition (NCT NCT04148482)

NCT ID: NCT04148482

Last Updated: 2025-07-23

Results Overview

Measurement of blood glucose at regular intervals.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

22 participants

Primary outcome timeframe

Day 1

Results posted on

2025-07-23

Participant Flow

Participant milestones

Participant milestones
Measure
Genotype of Interest Group
Individuals with desired genetic susceptibility will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Control
Individuals without genotype of interest (i.e., carrying the opposite genotype) will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Overall Study
STARTED
12
10
Overall Study
COMPLETED
12
10
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

PREMIER: PREvention of Metabolic Illness Through prEcision nutRition

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Genotype of Interest Group
n=12 Participants
Individuals with desired genetic susceptibility will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Control
n=10 Participants
Individuals without genotype of interest (i.e., carrying the opposite genotype) will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Total
n=22 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
n=5 Participants
7 Participants
n=7 Participants
18 Participants
n=5 Participants
Age, Categorical
>=65 years
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Age, Continuous
55.2 years
STANDARD_DEVIATION 8.9 • n=5 Participants
57.5 years
STANDARD_DEVIATION 8.3 • n=7 Participants
56.2 years
STANDARD_DEVIATION 8.5 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
7 Participants
n=7 Participants
14 Participants
n=5 Participants
Sex: Female, Male
Male
5 Participants
n=5 Participants
3 Participants
n=7 Participants
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
n=5 Participants
10 Participants
n=7 Participants
21 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
White
12 Participants
n=5 Participants
8 Participants
n=7 Participants
20 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
12 participants
n=5 Participants
10 participants
n=7 Participants
22 participants
n=5 Participants
Glucose at time 0
81.9 mg/dL
STANDARD_DEVIATION 11.7 • n=5 Participants
85.6 mg/dL
STANDARD_DEVIATION 8.3 • n=7 Participants
83.6 mg/dL
STANDARD_DEVIATION 10.2 • n=5 Participants

PRIMARY outcome

Timeframe: Day 1

Measurement of blood glucose at regular intervals.

Outcome measures

Outcome measures
Measure
Genotype of Interest Group
n=12 Participants
Individuals with desired genetic susceptibility will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Control
n=10 Participants
Individuals without genotype of interest (i.e., carrying the opposite genotype) will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Glucose at Times 30min, 60min, 120min, 180min
180min
80.8 mg/dL
Standard Deviation 12.5
81.9 mg/dL
Standard Deviation 9.4
Glucose at Times 30min, 60min, 120min, 180min
30min
112.9 mg/dL
Standard Deviation 19.3
119.8 mg/dL
Standard Deviation 15.6
Glucose at Times 30min, 60min, 120min, 180min
60min
94.5 mg/dL
Standard Deviation 24.1
118.4 mg/dL
Standard Deviation 34.3
Glucose at Times 30min, 60min, 120min, 180min
120min
84.1 mg/dL
Standard Deviation 22.5
94.1 mg/dL
Standard Deviation 10.9

PRIMARY outcome

Timeframe: Day 1

Number of participants with preference for a high-fat meal.

Outcome measures

Outcome measures
Measure
Genotype of Interest Group
n=12 Participants
Individuals with desired genetic susceptibility will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Control
n=10 Participants
Individuals without genotype of interest (i.e., carrying the opposite genotype) will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
High-fat Meal Preference
8 Participants
3 Participants

SECONDARY outcome

Timeframe: Day 1

Investigators will perform metabolomic profiling of plasma samples at regular intervals by using both targeted and untargeted approaches on an existing platform that measures \~10,000 metabolites (both polar and non-polar); they will compare their relative concentrations (fold change) by genotype at selected loci before and after the interventions. Metabolomics will be performed using LC-MS techniques in the Clish Laboratory of the Broad Institute of MIT and Harvard (Cambridge, MA). Fold-change in metabolite values (from 0-\>120, 0-\>240, and 240-\>360 minutes) will be statistically analyzed to identify distinct patterns of metabolite change in response to mixed meals by genotype. Examples of metabolomic fold-change readouts are provided below, by genotype - limited examples are provided as fold-change reporting for \~10,000 metabolites, identified and unidentified, at 3 time points would be impracticable.

Outcome measures

Outcome measures
Measure
Genotype of Interest Group
n=12 Participants
Individuals with desired genetic susceptibility will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Control
n=10 Participants
Individuals without genotype of interest (i.e., carrying the opposite genotype) will receive a standardized and an election meal in a full-day clinic visit. Dietary intervention: To investigate whether individuals with divergent genetic susceptibility have different food preferences and have differential post-prandial glycemic and metabolomics responses to a standardized or an election meal.
Metabolomics by Mass Spectrometry Analysis (Reported as Fold Change in Metabolites From Baseline)
taurodeoxycholic acid at 120 minutes
10.4 fold-change from baseline
Standard Deviation 8.8
4.2 fold-change from baseline
Standard Deviation 4.0
Metabolomics by Mass Spectrometry Analysis (Reported as Fold Change in Metabolites From Baseline)
glycochenodeoxycholic acid at 120 minutes
6.7 fold-change from baseline
Standard Deviation 5.3
3.9 fold-change from baseline
Standard Deviation 4.5

OTHER_PRE_SPECIFIED outcome

Timeframe: baseline, 120min, 240min, 360min

Population: Although these outcomes were initially proposed/intended, insufficient funds were available to collect or analyze these measures, and they were not ultimately collected.

Although these outcomes were initially proposed/intended, insufficient funds were available to collect or analyze these measures, and they were not ultimately collected.

Outcome measures

Outcome data not reported

Adverse Events

Genotype of Interest Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sara Cromer

Massachusetts General Hospital

Phone: 6177247303

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place